
About
Calixar Eurofins Discovery develops, produces, and characterizes recombinant membrane and soluble proteins for drug discovery, antibody development, and structural biology. It works with pharmaceutical, biotechnology, and academic teams from Lyon, France.
Services
Custom recombinant protein development
Develops fully functional, native proteins from sequence design through scale-up for drug discovery, antibody development, and structural biology.
Custom recombinant protein production
Expresses, purifies, and qualifies complex membrane and soluble proteins, including GPCRs and kinases, for downstream discovery workflows.
Protein analytics
Assesses purity, homogeneity, thermal stability, oligomeric state, aggregation, formulation screening, and activity.
Biophysics & molecular interactions
Measures binding affinity, kinetics, thermodynamics, stability, and mechanism of action using integrated biophysical methods.
Assays & in vitro testing
Structural biology support
Supports cryo-EM, X-ray crystallography, protein-ligand complex studies, and structure-based drug design.
- Turnaround
- 2 to 6 weeks
Capabilities
- Assays and studies
- SPR
- Antibodies
- Peptides
- Small molecules
- MST/TRIC
- ITC
7 more
- nanoDSF
- TSA
- Light scattering
- HT-Spectral Shift
- Thermal shift
- Aggregation monitoring
- Activity confirmation
- Scale and capacity
- Large-scale protein production
- Therapeutic areas
- Drug discovery
- Antibody development
Instruments and platforms
- Biacore 8K+
- MicroCal PEAQ-ITC
- Dianthus uHTS
- MonolithX
- Prometheus Panta
- CFX384
- CFX Opus 384
Modalities and species
- Modalities
- Small molecule
- Antibody
- Peptide
- Recombinant protein
- Species and models
- Human
Industries served
- Pharmaceutical
- Biotechnology
- Academic
- Life sciences
Company
- Type
- CRO
- Founded
- 2011
- Quality
- 100% In-house workflow (from sequence to quality control)
Locations
- Based in
- Lyon, France
- Serves
- Worldwide
Contacts
- Phone
- +33 481 076 460